Blake Hedstrom
General Manager – MindsEye
Overview
Blake Hedstrom is the General Manager of MindsEye at Pharaoh Neuro, where he leads the commercial strategy and go-to-market execution for the MindsEye™ Expandable Port. He brings more than a decade of experience spanning clinical operations, evidence strategy, and medical device commercialization across neuromodulation, urology, and neurocritical care.
Before joining Pharaoh Neuro, Blake held clinical and scientific leadership roles at Boston Scientific, Minnetronix Medical (now Forj), and Medtronic. His work has encompassed the full product lifecycle—from first-in-human feasibility through global post-market studies—including managing a $14M randomized post-market trial to support expanded reimbursement of a uro-oncology device and leading the field team that supported the PILLAR and PILLAR-XT trials of Pharaoh’s Neurapheresis™ platform. Notably, his direct experience commercializing the MindsEye technology and supporting the Neurapheresis platform during his tenure at Minnetronix Medical gives him deep, hands-on familiarity with the Pharaoh product portfolio and the neurosurgical customers it serves.
Before joining Pharaoh Neuro, Blake held clinical and scientific leadership roles at Boston Scientific, Minnetronix Medical (now Forj), and Medtronic. His work has encompassed the full product lifecycle—from first-in-human feasibility through global post-market studies—including managing a $14M randomized post-market trial to support expanded reimbursement of a uro-oncology device and leading the field team that supported the PILLAR and PILLAR-XT trials of Pharaoh’s Neurapheresis™ platform. Notably, his direct experience commercializing the MindsEye technology and supporting the Neurapheresis platform during his tenure at Minnetronix Medical gives him deep, hands-on familiarity with the Pharaoh product portfolio and the neurosurgical customers it serves.
Blake pairs clinical fluency with commercial rigor, having built and led high-performing cross-functional teams, cultivated strong relationships with HCPs, and driven work recognized for both scientific and financial impact, including a Boston Scientific VIP Platinum Award for identifying $1.1M in cost avoidance through strategic use of existing clinical data. He holds a B.A. in Psychology with a minor in Neuroscience from St. Olaf College and an M.A. in Neuroscience from Washington University in St. Louis.
As General Manager of MindsEye, he brings this combination of clinical depth, commercial discipline, and product-specific expertise to scale MindsEye adoption and accelerate its impact in the neurosurgical market.
As General Manager of MindsEye, he brings this combination of clinical depth, commercial discipline, and product-specific expertise to scale MindsEye adoption and accelerate its impact in the neurosurgical market.
Social Links
